Precision Cell Systems Acquires BennuBio, Expanding Presence in 3D Cell Culture Market

PCS's acquisition of BennuBio marks a significant entry into the rapidly growing 3D cell culture market, enhancing its capabilities in single-cell analysis, cell therapy, drug discovery, and bioprocessing applications.